Metabolic syndrome and hypertension: Pathophysiology and molecular basis of insulin resistance

Basic Research in Cardiology

Volumn 93, Issue 2 SUPPL., 1998, Pages 131-134

  Muller Wieland D ^a   Kotzka, J ^a   Knebel, B ^a   Krone, W ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Cholesterol; Hypertension; Insulin resistance; Metabolic syndrome; Obesity

Indexed keywords

ANGIOTENSINOGEN; CHOLESTEROL; ENDOTHELIN 1; FATTY ACID; MITOGEN ACTIVATED PROTEIN KINASE; STEROL CARRIER PROTEIN; STEROL CARRIER PROTEIN 2;

ADIPOCYTE; ARTERIAL PRESSURE; CHOLESTEROL METABOLISM; CONFERENCE PAPER; CORONARY RISK; DYSLIPIDEMIA; DYSLIPOPROTEINEMIA; ENDOTHELIUM; ESSENTIAL HYPERTENSION; FATTY ACID METABOLISM; GENE CONTROL; GENE EXPRESSION; GENETICS; GLUCOSE INTOLERANCE; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MOLECULAR BIOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; SYMPATHETIC TONE; SYNDROME X; VASODILATATION;

CHOLESTEROL; GENE EXPRESSION REGULATION; HUMANS; HYPERTENSION; INSULIN RESISTANCE; METABOLIC DISEASES; OBESITY;

EID: 0031737515     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s003950050238     Document Type: Article

References (16)

1. Bao W, Srinivasan SR, Berenson GS (1996) Persistant elevation of plasma insulin level is associated with increased cardiovascular risk in children and young adults. The Bogalusa Heart Study. Circulation 93: 54-59 (Pubitemid 26006568)
2. Blum WF, Kiess W, Rascher W (1997) Leptin - The voice of adipose tissue. Johann Ambrosius Barth Verlag, Heidelberg Leipzig
3. Brown MS, Goldstein JL (1997) The SREBPpathway: Regulation of cholesterol metabolism by proteolysis of a membranebound transcription factor. Cell 89: 331-340 (Pubitemid 27220877)
4. DeFronzo RA, Ferrannini E (1991) Insulin resistance: A multifaced syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiocasclar disease. Diabetes Care 14: 173-194
5. Ferranini E, Buzzigoli G, Bonadonna R et al. (1987) Insulin resistance in essential hypertension. N Engl J Med 317: 350-357 (Pubitemid 17118813)
6. Haffner SM, Valdez RA, Hazuda HP, Mitzbell BD, Morales PA, Stern PA(1992) Prospective analysis of the insulin resistance syndrome (Syndrome X). Diabetes 41: 7115-7122
7. Hopkins PM, Hunt SC, Wu LL, Williams GH, Williams RR (1996) Hypertesion, dyslipidaemia and insulin resistance: Links in a chain or spokes on a view? Curr Opin Lipidol: 241-251
8. Müller-Wieland D, Kotzka J, Krone W (1997) Stabilization of atherosclerotic plaque during lipid lowering. Curr Opin Lipidol 8: 348-353 (Pubitemid 27504220)
9. Robinson MJ, Cobb MH (1997) Curr Opin Cell Biol 9: 180-186
10. Scherrer U, Sartori C (1997) Insulin as a vascular sympathoexcitatory hormone. Circulation 96: 4104-4113
11. Spiegelman BM, Flier JS (1996) Adipogenesis and obesity: Rounding out the big picture. Cell 87: 377-389 (Pubitemid 26374313)
12. Spiegelman BM (1998) PPAR: Adipogenic regulator and thiazolidiedione receptor. Diabetes 47: 507-514 (Pubitemid 28160438)
13. Srinivasan SR, Bao W, Wattigne BA, Berenson GS (1996) Adolescent overweight associated with adult overweight and related multiple cardiovascular risk factors: The Bogalusa Heart Study. Metabolism 45: 135-240
14. Streicher R, Kotzka J, Müller-Wieland D, Siemeister G, Munck M, Avci H, Krone W (1996) SREBP-1 mediates activation of the low density lipoprotein receptor promoter by insulin and insulin-like growth factor-1. J Biol Chem 271: 7128-7133 (Pubitemid 26104151)
15. Weidmann P, Courten M, Böhler LM, Shore F (1993) The pathogenesis of hypertension and obese subjects. Durg 46: 197-209
16. Yenush L, White MF (1997) The IRSsignaling system during insulin and cytokine action. BioEssay 19: 491-500 (Pubitemid 27299497)